Current Radiopharmaceuticals

Editor-in-Chief

Sean L. Kitson
Department of Biocatalysis and Isotope Chemistry Almac Sciences
Almac House
Craigavon
(Northern Ireland)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



Meet Our Editorial Board Member free to download

Volume:11   Issue: 3
Pp: 153-153
Alan C. Spivey
DOI: 10.2174/187447101103180911115205
Published on: 21 October, 2018



The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications free to download

Volume:11   Issue: 3
Pp: 154-155
Valery Radchenko, Paul Schaffer and F.F. (Russ) Knapp
DOI: 10.2174/187447101103180911115600
Published on: 21 October, 2018



Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences open access plus

Volume:11   Issue: 3
Pp: 156-172
Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*
DOI: 10.2174/1874471011666180416161908
Published on: 21 October, 2018




The Production of Ac-225

Volume:11   Issue: 3
Pp: 173-179
Jonathan W. Engle*
DOI: 10.2174/1874471011666180418141357
Published on: 21 October, 2018




NorthStar Perspectives for Actinium-225 Production at Commercial Scale

Volume:11   Issue: 3
Pp: 180-191
James T. Harvey*
DOI: 10.2174/1874471011666180515123848
Published on: 21 October, 2018




Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies

Volume:11   Issue: 3
Pp: 192-199
Joseph G. Jurcic*
DOI: 10.2174/1874471011666180525102814
Published on: 21 October, 2018




An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth open access plus

Volume:11   Issue: 3
Pp: 200-208
Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer
DOI: 10.2174/1874471011666180502104524
Published on: 21 October, 2018




Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides

Volume:11   Issue: 3
Pp: 209-214
George Sgouros*, Robert Hobbs and Anders Josefsson
DOI: 10.2174/1874471011666180426130058
Published on: 21 October, 2018




In vivo Evaluation of Free and Chelated Accelerator-produced Actinium- 225 - Radiation Dosimetry and Toxicity Results

Volume:11   Issue: 3
Pp: 215-222
Zewei Jiang, Ekaterina Revskaya, Darrell R. Fisher and Ekaterina Dadachova*
DOI: 10.2174/1874471011666180423120707
Published on: 21 October, 2018




In vivo Evaluation of [225Ac]Ac-DOTAZOL for α-Therapy of Bone Metastases

Volume:11   Issue: 3
Pp: 223-230
Nina Pfannkuchen, Nicole Bausbacher, Stefanie Pektor, Matthias Miederer and Frank Rosch*
DOI: 10.2174/1874471011666180604083911
Published on: 21 October, 2018




Acknowledgement to Reviewers free to download

Volume:11   Issue: 3
Pp: 231-231

DOI: 10.2174/187447101103180911121741
Published on: 21 October, 2018



Editor's Note free to download

Volume:11   Issue: 3
Pp: 232-232

DOI: 10.2174/187447101103181022123221
Published on: 21 October, 2018